Does distance from a clinic and poverty impact visit adherence for noncommunicable diseases? A retrospective cohort study using electronic medical records in rural Haiti.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
14 Oct 2020
Historique:
received: 07 07 2020
accepted: 07 10 2020
entrez: 15 10 2020
pubmed: 16 10 2020
medline: 15 5 2021
Statut: epublish

Résumé

Adherence to regular outpatient visits is vital to managing noncommunicable diseases (NCDs), a growing burden in low and middle-income countries. We characterized visit adherence among patients with NCDs in rural Haiti, hypothesizing higher poverty and distance from the clinic were associated with lower adherence. We analyzed electronic medical records from a cohort of adults in an NCD clinic in Mirebalais, Haiti (April 2013 to June 2016). Visit adherence was: 1) visit constancy (≥1 visit every 3 months), 2) no gaps in care (> 60 days between visits), 3) ≥1 visit in the last quarter, and 4) ≥6 visits per year. We incorporated an adapted measure of intensity of multidimensional poverty. We calculated distance from clinic as Euclidean distance or self-reported transit time. We used multivariable logistic regressions to assess the association between poverty, distance, and visit adherence. We included 463 adult patients, mean age 57.8 years (SE 2.2), and 72.4% women. Over half of patients had at least one visit per quarter (58.1%), but a minority (19.6%) had no gaps between visits. Seventy percent of patients had a visit in the last quarter, and 73.9% made at least 6 visits per year. Only 9.9% of patients met all adherence criteria. In regression models, poverty was not associated with any adherence measures, and distance was only associated with visit in the last quarter (OR 0.87, 95% CI [0.78 to 0.98], p = 0.03) after adjusting for age, sex, and hardship financing. Visit adherence was low in this sample of adult patients presenting to a NCD Clinic in Haiti. Multidimensional poverty and distance from clinic were not associated with visit adherence measures among patients seen in the clinic, except for visit in the last quarter. Future research should focus on identifying and addressing barriers to visit adherence.

Sections du résumé

BACKGROUND BACKGROUND
Adherence to regular outpatient visits is vital to managing noncommunicable diseases (NCDs), a growing burden in low and middle-income countries. We characterized visit adherence among patients with NCDs in rural Haiti, hypothesizing higher poverty and distance from the clinic were associated with lower adherence.
METHODS METHODS
We analyzed electronic medical records from a cohort of adults in an NCD clinic in Mirebalais, Haiti (April 2013 to June 2016). Visit adherence was: 1) visit constancy (≥1 visit every 3 months), 2) no gaps in care (> 60 days between visits), 3) ≥1 visit in the last quarter, and 4) ≥6 visits per year. We incorporated an adapted measure of intensity of multidimensional poverty. We calculated distance from clinic as Euclidean distance or self-reported transit time. We used multivariable logistic regressions to assess the association between poverty, distance, and visit adherence.
RESULTS RESULTS
We included 463 adult patients, mean age 57.8 years (SE 2.2), and 72.4% women. Over half of patients had at least one visit per quarter (58.1%), but a minority (19.6%) had no gaps between visits. Seventy percent of patients had a visit in the last quarter, and 73.9% made at least 6 visits per year. Only 9.9% of patients met all adherence criteria. In regression models, poverty was not associated with any adherence measures, and distance was only associated with visit in the last quarter (OR 0.87, 95% CI [0.78 to 0.98], p = 0.03) after adjusting for age, sex, and hardship financing.
CONCLUSIONS CONCLUSIONS
Visit adherence was low in this sample of adult patients presenting to a NCD Clinic in Haiti. Multidimensional poverty and distance from clinic were not associated with visit adherence measures among patients seen in the clinic, except for visit in the last quarter. Future research should focus on identifying and addressing barriers to visit adherence.

Identifiants

pubmed: 33054756
doi: 10.1186/s12889-020-09652-y
pii: 10.1186/s12889-020-09652-y
pmc: PMC7556963
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1545

Subventions

Organisme : American Heart Association
ID : 18SFRN34110082
Organisme : NHLBI NIH HHS
ID : R01HL128914, 2R01 HL092577; 2U54HL120163, 1R01 HL141434 01A1, 1R01AG066010
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL140133
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23HL140133
Pays : United States
Organisme : American Heart Association (US)
ID : 17MCPRP33460298
Organisme : Health Resources and Services Administration (US)
ID : D33 HP 25766, D33 HP 29243
Organisme : Robert Wood Johnson
ID : 74624

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Trop Med Int Health. 2010 Jun;15 Suppl 1:63-9
pubmed: 20586962
PLoS One. 2015 Jun 18;10(6):e0129376
pubmed: 26086089
J Int Assoc Provid AIDS Care. 2014 Jan-Feb;13(1):78-84
pubmed: 23269515
HIV Med. 2017 Apr;18(4):267-274
pubmed: 27535219
BMC Public Health. 2019 Apr 5;19(1):383
pubmed: 30953503
Am Heart J. 2016 Aug;178:151-60
pubmed: 27502863
PLoS Med. 2016 Nov 29;13(11):e1002183
pubmed: 27898679
PLoS Med. 2011 Oct;8(10):e1001111
pubmed: 22039357
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
JAMA. 2008 Aug 6;300(5):506-7
pubmed: 18677022
Bull World Health Organ. 2010 Sep 1;88(9):681-8
pubmed: 20865073
S Afr Med J. 2007 Sep;97(9):853-7
pubmed: 17985056
Health Aff (Millwood). 2009 Jul-Aug;28(4):1056-66
pubmed: 19597204
Trop Med Int Health. 2008 Mar;13(3):328-33
pubmed: 18298607
J Infect Dis. 2017 Dec 1;216(suppl_9):S851-S856
pubmed: 29207000
BMJ Open. 2018 Apr 20;8(4):e020317
pubmed: 29678978
Lancet. 2016 Apr 2;387(10026):1377-1396
pubmed: 27115820
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
AIDS Behav. 2018 Sep;22(9):3009-3023
pubmed: 29603112
J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):e61-9
pubmed: 23254154
Glob Heart. 2020 Feb 06;15(1):7
pubmed: 32489780
Clin Infect Dis. 2007 Jun 1;44(11):1493-9
pubmed: 17479948
J Int AIDS Soc. 2016 Jul 04;19(1):20859
pubmed: 27389256
AIDS Res Ther. 2016 Nov 8;13:35
pubmed: 27826353
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
Heart. 2016 Jan;102(2):140-6
pubmed: 26729609
AIDS Behav. 2013 Nov;17(9):3145-51
pubmed: 23868692
Lancet. 2018 Jul 21;392(10143):245-252
pubmed: 29866374
Curr HIV/AIDS Rep. 2010 Nov;7(4):234-44
pubmed: 20820972
J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):e123-30
pubmed: 25162815
PLoS One. 2010 Apr 28;5(4):e10340
pubmed: 20442769
J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):574-80
pubmed: 23011397

Auteurs

Lily D Yan (LD)

Boston Medical Center, 72 East Concord St., Boston, MA, 02118, USA.

Dufens Pierre-Louis (D)

Zanmi Lasante, Cange, Haiti.
Hôpital Universitaire de Mirebalais, Mirebalais, Haiti.

Benito D Isaac (BD)

Zanmi Lasante, Cange, Haiti.

Waking Jean-Baptiste (W)

Zanmi Lasante, Cange, Haiti.
Hôpital Universitaire de Mirebalais, Mirebalais, Haiti.

Serge Vertilus (S)

Zanmi Lasante, Cange, Haiti.
Hôpital Universitaire de Mirebalais, Mirebalais, Haiti.

Darius Fenelon (D)

Zanmi Lasante, Cange, Haiti.

Lisa R Hirschhorn (LR)

Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Patricia L Hibberd (PL)

Boston University School of Medicine, Boston, MA, USA.
Boston University School of Public Health, Boston, MA, USA.

Emelia J Benjamin (EJ)

Boston University School of Medicine, Boston, MA, USA.
Boston University School of Public Health, Boston, MA, USA.

Gene Bukhman (G)

Partners In Health, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Brigham and Women's Hospital, Boston, MA, USA.

Gene F Kwan (GF)

Boston Medical Center, 72 East Concord St., Boston, MA, 02118, USA. genekwan@bu.edu.
Boston University School of Medicine, Boston, MA, USA. genekwan@bu.edu.
Partners In Health, Boston, MA, USA. genekwan@bu.edu.
Harvard Medical School, Boston, MA, USA. genekwan@bu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH